We work with pharma and biotech companies to accelerate start-ups in Life Sciences, providing critical technologies/services for vaccines and other therapeutics
Greater New York City area
Joined December 2015
- Tweets226
- Following267
- Followers183
- Likes99
Dynamk Capital retweeted
A randomized #clinicaltrial found that the simultaneous administration of #mRNA COVID-19 and inactivated influenza vaccines 💉 has similar safety and reactogenicity compared to sequential administration. Read the study 📘: hubs.la/Q02YZLTZ0
Dynamk Capital retweeted
ZEISS and Alpenglow Biosciences today announced a new partnership to jointly develop an inverted light-sheet microscope and bioinformatics pipeline tailored specifically for clinical applications. Read the Full Press Release: businesswire.com/news/home/2…
Dynamk Capital retweeted
Curi Bio and Cook MyoSite Announce Strategic Partnership - bioinformant.com/curi-bio-an…
@Curi_Bio @CookMyosite
Dynamk Capital retweeted
RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing - bioinformant.com/roosterbio-…
@RoosterBio @thermofisher
Dynamk Capital retweeted
📗 A study led by @uchicago_obgyn professor Dr. Ayman Al Hendy and colleagues recently explored ex vivo #exosome therapy models to pursue a novel, potentially safer alternative to hormone replacement therapy (HRT) for managing perimenopausal symptoms.
mdpi.com/1422-0067/25/13/707…
Dynamk Capital retweeted
RoosterBio is proud to announce that Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of @NikonUSA Corporation, has entered into a strategic licensing agreement with RoosterBio. Read the full press release here.⤵️ roosterbio.com/press_release…
Dynamk Capital retweeted
RoosterBio cells, media, and bioprocess tools are helping power clinical trials in human patients. This blog highlights 2 researchers who used RoosterBio products to rapidly launch first-in-human studies for eye disease and post-COVID lung fibrosis.⤵️
roosterbio.com/blog/roosterb…
Dynamk Capital retweeted
Curi Bio is excited to announce the grand opening of our new global headquarters in Seattle! The state-of-the-art facility expands our capacity to unlock critical functional human data that informs biopharmaceutical R&D decision-making.
Read More: hubs.ly/Q03gr5PK0
Dynamk Capital retweeted
Vernal Biosciences on LinkedIn: #mrna #mrnadevelopment #mrna #biotech #innovation #efficiency… hubs.la/Q031tfp90
Dynamk Capital retweeted
When you are a highly disruptive entrepreneur in Life Sciences, there is ways to realize your full potential.
Thanks to @DynamkVC and Gustavo Mahler for their insight.
#privateequity #lifesciences #investmentstrategy #scouting lnkd.in/eka2aWt
Dynamk Capital retweeted
That crashing you hear? It's the sound of the glass ceiling shattering. #FearlessGirl #shareworthy
Dynamk Capital retweeted
We are so proud to have been named a 2020 #TopWorkplace by Washington Post! A big thank you to all of our employees who helped make this happen!
lnkd.in/d6rX2dA
#TheRoost #Roosters #lovewhereyouwork #culturematters #bestplacestowork
Dynamk Capital retweeted
#COVID19 Clinical Pipeline: 135 #antivirals in development: 33 clinical compounds, 102 preclinical compounds. See more at our #coronavirus tracker: buff.ly/3fV16JG
Dynamk Capital retweeted
As researchers and scientists look to stop the spread of #COVID19, what were once apparent “dead ends in drug development” could provide the answers we need. More here: buff.ly/3dHOSTl
Dynamk Capital retweeted
Nothing Stops Innovation. For 2020, the BIO International Convention will be moved to an online platform: #BIODigital, June 8-12, 2020. Hear more from BIO President & CEO Jim Greenwood. bit.ly/3437Orz
Dynamk Capital retweeted
Dr. Gustavo Mahler Now a General Partner at Dynamk Capital dynamk.vc/news/gustavo-mahle… – at Manhattan, NY
Dynamk Capital retweeted
We are committed to being your trusted supplier of hMSCs, media products and process development services.
A letter from CEO Margot Connor on RoosterBio's COVID-19 response to our customers:
lnkd.in/d_TBi3Y
#COVID19 #regenerativemedicine #biomanufacturing #supplychain
Dynamk Capital retweeted
From the RoosterBlog | Efforts to treat damage to lungs or facilitate rehabilitation in #COVID-19 may reap plausible benefit via allogeneic mesenchymal stem/stromal cells (#MSCs): hubs.ly/H0nBs1Z0
#regenerativemedicine #celltherapy #COVID19
Dynamk Capital retweeted
NEWS RELEASE | RoosterBio partners with @SentiBio to rapidly translate #gene circuit #celltherapy into the clinic. The collaboration accelerates the clinical translation of Senti’s #gene-modified cell therapies for #ovariancancer and other solid tumors: bit.ly/3b4a57U